无症状围术期心肌损伤与肾下腹主动脉瘤腔内修复术后远期生存受损相关:一项回顾性研究
围术期心肌损伤(PMI)定义为术前与术后高敏肌钙蛋白T(hsTnT)差值≥14 ng/L且无心肌缺血临床表现,发生率为11.9%。PMI患者6年死亡风险显著更高(42.1% vs. 23.6%,校正HR 2.11,95%CI 1.13-3.92;
要点
- EVAR术后无症状PMI发生率为11.9%,与6年死亡风险升高独立相关。
- hsTnT是识别EVAR患者围术期心脏损伤的敏感标志物。
- 他汀治疗与死亡风险降低独立相关(校正HR 0.40)。
核心结论
- 无症状PMI在EVAR术后相对常见,并与远期生存受损相关。
- hsTnT是识别EVAR患者心脏损伤的敏感标志物。
- PMI与EVAR术后死亡的潜在关联需前瞻性研究进一步证实,并明确强化术后心脏监护的获益。
研究设计与样本
- 回顾性分析2012至2022年荷兰一家三级医院接受标准肾下EVAR的患者术前及连续术后hsTnT水平。
- PMI定义为术前与术后hsTnT差值≥14 ng/L且无心肌缺血临床表现,临床显性心肌梗死患者被排除。
主要发现
- PMI发生于38例患者(11.9%)。
关键数值与推荐
- PMI定义:术前与术后hsTnT差值≥14 ng/L,无心肌缺血临床表现。
- 主要结局:PMI发生率及远期死亡率;次要结局:ΔhsTnT幅度与远期死亡率的关联。
临床怎么用
- EVAR围术期应监测hsTnT以识别无症状PMI。
- 对发生PMI的患者应考虑强化术后心脏监护与随访。
- 他汀治疗与较低死亡风险相关,围术期应关注其使用。
局限性
- 回顾性研究设计。
- 单中心研究。
- PMI与EVAR术后死亡的关联需前瞻性研究进一步证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Peri-operative myocardial injury (PMI) is characterised by an acute but clinically asymptomatic increase in troponin levels. Its incidence in vascular surgery is under-reported. Moreover, the impact of PMI on survival in patients undergoing endovascular aneurysm repair (EVAR), who are particularly at risk owing to their cardiovascular burden, remains unclear. This study aimed to assess the incidence of PMI following infrarenal EVAR and its association with long term mortality. METHODS: Pre- and consecutive post-operative high sensitivity troponin T (hsTnT) levels were retrospectively analysed from patients who underwent standard infrarenal EVAR in a tertiary Dutch hospital between 2012 and 2022. PMI was defined as a difference of ≥ 14 ng/L (ΔhsTnT) between pre- and post-operative troponin concentrations without clinical features of myocardial ischaemia. Patients with clinically evident myocardial infarction were excluded. The primary outcomes were the incidence of PMI and the long term mortality rate. A secondary outcome was the association between the magnitude of ΔhsTnT and long term mortality rate, irrespective of PMI criteria. RESULTS: Three hundred and eighteen patients were included, with a median follow up of 43 months. PMI occurred in 38 patients (11.9%). The six year risk of death was statistically significantly higher in patients with PMI (42.1% vs. 23.6%, adjusted hazard ratio [HR] 2.11, 95% confidence interval [CI] 1.13 - 3.92; p = .019). Age (adjusted HR 1.06, 95% CI 1.02 - 1.09; p ≤ .001) and American Society of Anesthesiologists score (adjusted HR 1.82, 95% CI 1.16 - 2.87; p = .009) were independent predictors of death. Statin therapy demonstrated protective advantages against death (adjusted HR 0.40, 95% CI 0.25 - 0.65; p < .001). Lastly, there was a statistically significant association between the magnitude of ΔhsTnT and long term death (adjusted HR = 1.016/Δ1 ng/L, 95% CI 1.004 - 1.029; p = .012). CONCLUSION: Asymptomatic PMI is relatively common following EVAR and is associated with impaired long term survival. HsTnT is a sensitive marker for identifying cardiac damage in patients undergoing EVAR. Prospective studies may strengthen the evidence of the potential association between PMI and post-EVAR death and clarify any benefit from intensified post-operative cardiac care.
引用
- Vecht DE, van Tongeren OLRM, Rastogi V, et al. Impaired Long Term Survival with Asymptomatic Peri-operative Myocardial Injury following Endovascular Infrarenal Abdominal Aortic Aneurysm Repair: A Retrospective Study. Eur J Vasc Endovasc Surg. 2025. PMID: 40840792. doi:10.1016/j.ejvs.2025.08.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。